Ipopema Securities SA (IPE) - Net Assets
Based on the latest financial reports, Ipopema Securities SA (IPE) has net assets worth zł148.49 Million PLN (≈ $40.87 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł631.81 Million ≈ $173.88 Million USD) and total liabilities (zł483.32 Million ≈ $133.02 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check IPE capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł148.49 Million |
| % of Total Assets | 23.5% |
| Annual Growth Rate | 7.13% |
| 5-Year Change | 23.07% |
| 10-Year Change | 70.93% |
| Growth Volatility | 13.46 |
Ipopema Securities SA - Net Assets Trend (2008–2025)
This chart illustrates how Ipopema Securities SA's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Ipopema Securities SA market capitalisation.
Annual Net Assets for Ipopema Securities SA (2008–2025)
The table below shows the annual net assets of Ipopema Securities SA from 2008 to 2025. Also explore Ipopema Securities SA (IPE) net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | zł142.95 Million ≈ $39.34 Million |
+12.19% |
| 2024-12-31 | zł127.43 Million ≈ $35.07 Million |
+0.46% |
| 2023-12-31 | zł126.85 Million ≈ $34.91 Million |
+12.57% |
| 2022-12-31 | zł112.69 Million ≈ $31.01 Million |
-2.99% |
| 2021-12-31 | zł116.16 Million ≈ $31.97 Million |
+1.93% |
| 2020-12-31 | zł113.96 Million ≈ $31.36 Million |
+36.08% |
| 2019-12-31 | zł83.74 Million ≈ $23.05 Million |
+4.15% |
| 2018-12-31 | zł80.41 Million ≈ $22.13 Million |
-4.51% |
| 2017-12-31 | zł84.20 Million ≈ $23.17 Million |
+0.68% |
| 2016-12-31 | zł83.64 Million ≈ $23.02 Million |
-0.92% |
| 2015-12-31 | zł84.41 Million ≈ $23.23 Million |
+4.56% |
| 2014-12-31 | zł80.72 Million ≈ $22.22 Million |
-5.41% |
| 2013-12-31 | zł85.34 Million ≈ $23.49 Million |
+13.44% |
| 2012-12-31 | zł75.23 Million ≈ $20.70 Million |
-7.09% |
| 2011-12-31 | zł80.97 Million ≈ $22.28 Million |
+16.92% |
| 2010-12-31 | zł69.25 Million ≈ $19.06 Million |
+42.67% |
| 2009-12-31 | zł48.54 Million ≈ $13.36 Million |
+9.41% |
| 2008-12-31 | zł44.37 Million ≈ $12.21 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ipopema Securities SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 251.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł118.27 Million | 87.20% |
| Common Stock | zł2.99 Million | 2.21% |
| Other Comprehensive Income | zł4.02 Million | 2.96% |
| Other Components | zł10.35 Million | 7.63% |
| Total Equity | zł135.64 Million | 100.00% |
Ipopema Securities SA Competitors by Market Cap
The table below lists competitors of Ipopema Securities SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELO
|
$76.34 Million |
|
Trias Sentosa Tbk
JK:TRST
|
$76.35 Million |
|
INSUN Environmental New Technology Co. Ltd
KQ:060150
|
$76.36 Million |
|
Country Group Holdings Public Company Limited
BK:CGH
|
$76.36 Million |
|
Helix BioPharma Corp.
TO:HBP
|
$76.25 Million |
|
Sejal Glass Limited
NSE:SEJALLTD
|
$76.23 Million |
|
Woorim Machinery Co. Ltd
KQ:101170
|
$76.22 Million |
|
Ribbon Acquisition Corp Unit
NASDAQ:RIBBU
|
$76.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ipopema Securities SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 120,864,000 to 135,639,000, a change of 14,775,000 (12.2%).
- Net income of 23,857,000 contributed positively to equity growth.
- Dividend payments of 6,287,000 reduced retained earnings.
- Other comprehensive income increased equity by 304,999.
- Other factors decreased equity by 3,099,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł23.86 Million | +17.59% |
| Dividends Paid | zł6.29 Million | -4.64% |
| Other Comprehensive Income | zł305.00K | +0.22% |
| Other Changes | zł-3.10 Million | -2.29% |
| Total Change | zł- | 12.22% |
Book Value vs Market Value Analysis
This analysis compares Ipopema Securities SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.86x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.97x to 1.86x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | zł1.55 | zł9.26 | x |
| 2009-12-31 | zł1.63 | zł9.26 | x |
| 2010-12-31 | zł2.30 | zł9.26 | x |
| 2011-12-31 | zł2.61 | zł9.26 | x |
| 2012-12-31 | zł2.42 | zł9.26 | x |
| 2013-12-31 | zł2.71 | zł9.26 | x |
| 2014-12-31 | zł2.57 | zł9.26 | x |
| 2015-12-31 | zł2.70 | zł9.26 | x |
| 2016-12-31 | zł2.65 | zł9.26 | x |
| 2017-12-31 | zł2.67 | zł9.26 | x |
| 2018-12-31 | zł2.53 | zł9.26 | x |
| 2019-12-31 | zł2.64 | zł9.26 | x |
| 2020-12-31 | zł3.64 | zł9.26 | x |
| 2021-12-31 | zł3.71 | zł9.26 | x |
| 2022-12-31 | zł3.58 | zł9.26 | x |
| 2023-12-31 | zł4.03 | zł9.26 | x |
| 2024-12-31 | zł4.04 | zł9.26 | x |
| 2025-12-31 | zł4.98 | zł9.26 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ipopema Securities SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.59%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.04%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 3.50x
- Recent ROE (17.59%) is above the historical average (13.00%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 28.20% | 23.33% | 0.39x | 3.13x | zł8.08 Million |
| 2009 | 24.93% | 16.67% | 0.18x | 8.18x | zł7.04 Million |
| 2010 | 27.30% | 18.34% | 0.25x | 6.05x | zł11.67 Million |
| 2011 | 31.58% | 21.80% | 0.18x | 8.13x | zł16.73 Million |
| 2012 | 12.56% | 9.62% | 0.12x | 11.00x | zł1.85 Million |
| 2013 | 10.31% | 7.84% | 0.30x | 4.34x | zł247.80K |
| 2014 | 6.01% | 4.44% | 0.32x | 4.22x | zł-3.07 Million |
| 2015 | 4.82% | 3.98% | 0.28x | 4.37x | zł-4.19 Million |
| 2016 | 1.85% | 1.66% | 0.26x | 4.30x | zł-6.46 Million |
| 2017 | 2.07% | 1.70% | 0.27x | 4.53x | zł-6.34 Million |
| 2018 | -3.87% | -2.99% | 0.38x | 3.43x | zł-10.52 Million |
| 2019 | 3.94% | 2.23% | 0.52x | 3.43x | zł-4.80 Million |
| 2020 | 27.23% | 11.50% | 0.44x | 5.40x | zł18.78 Million |
| 2021 | 11.80% | 5.11% | 0.61x | 3.79x | zł2.00 Million |
| 2022 | 5.17% | 2.13% | 0.68x | 3.54x | zł-5.17 Million |
| 2023 | 15.06% | 5.61% | 0.77x | 3.49x | zł6.11 Million |
| 2024 | 7.53% | 3.54% | 0.71x | 3.00x | zł-2.98 Million |
| 2025 | 17.59% | 8.04% | 0.62x | 3.50x | zł10.29 Million |
Industry Comparison
This section compares Ipopema Securities SA's net assets metrics with peer companies in the Capital Markets industry.
Industry Context
- Industry: Capital Markets
- Average net assets among peers: $177,622,412
- Average return on equity (ROE) among peers: 66.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ipopema Securities SA (IPE) | zł148.49 Million | 28.20% | 3.25x | $76.30 Million |
| Dom Maklerski IDM SA (IDM) | $2.23 Million | 337.63% | 1.44x | $5.73 Million |
| INC S.A. (INC) | $30.31 Million | -8.37% | 0.06x | $6.20 Million |
| Novavis Group SA (NVG) | $5.31 Million | 53.86% | 2.47x | $6.53 Million |
| Reino Capital SA (RNC) | $60.99 Million | -4.91% | 0.15x | $36.58 Million |
| Skyline Investment S.A. (SKL) | $51.34 Million | -6.35% | 0.75x | $9.56 Million |
| X Trade Brokers Dom Maklerski SA (XTB) | $915.56 Million | 25.98% | 2.44x | $4.63 Billion |
About Ipopema Securities SA
IPOPEMA Securities S.A., together with its subsidiaries, provides brokerage, company analysis, and investment banking services in Poland. The company engages in the brokerage and investment banking activities; distribution of investment products; and provision of investment advisory services to a range of individual investors, as well as advisory services related to corporate financial restructur… Read more